By Professor Bruce Neal

Journal articles

Dudman N; Hunt D; MacMahon S; Neal B; Richards M; Simes J; Tonkin A; Wilcken D; Murphy J; Cleverly Y; Keech A; Ohkubo T; Bos K; Bartram H; Bennett D; Broad J; Douglas D; Fisher S; Gray B; Milne A; McCulloch A; Ng C; Pledger M; Pryor A; Santos A; Slater A; Yiu K; Brnabic A; Woodward M; Burrell L; Brown L; Hamer A; Roberts L; Jeffery I; Taverner P; Kam A; Aylward P; Wollaston F; Whitehead A; Lane G; Tulloch G; Forrest N; Garrett J; Aroney G; Hicks P; Silberberg J; Gordon A; Holliday J; Hicks L; Singh B; Singh C; Wilken J; Jackson B; Rudge G; West M; Carle A; Marwick T; Hall C; Cross D; Craw D; Hunt D; Sallaberger M; Horowitz J; Worthley M; Owen L; Owensby D; McKenzie B; Kesby-Smith J; MacKinley S; Sharpe N; Doughty R; Pomfret J; Richards M; Buttimore R; Skelton L; Williams M; Stewart R; McLelland M; Luke R; Kenyon J; Mann S; Cuthbert A; Reubin S; Yorke P; Scott D; Williams M; Coxon R; Fry D; Clark M; Barclay P; Hart H; O'Toole C; Wright P; Nairn L; Bruning J, 2002, 'Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease', European Heart Journal, 23, pp. 1509 - 1515, http://dx.doi.org/10.1053/euhj.2002.3161

Watanabe M; Barzi F; Neal B; Ueshima H; Miyoshi Y; Okayama A; Reza Choudhury S, 2002, 'Alcohol consumption and the risk of diabetes by body mass index levels in a cohort of 5,636 Japanese', Diabetes Research and Clinical Practice, 57, pp. 191 - 197, http://dx.doi.org/10.1016/S0168-8227(02)00083-9

Neal B, 2001, 'Review: ACE inhibitors, calcium antagonists, and more intensive blood pressure lowering strategies reduce cardiovascular events', Evidence-Based Medicine, 6, pp. 111, http://dx.doi.org/10.1136/ebm.6.4.111

Cruickshank J, 2001, 'The lowering of blood pressure after stroke', LANCET, 358, pp. 1994 - 1994, http://dx.doi.org/10.1016/S0140-6736(01)06981-1

MacMahon S; Rodgers A; Neal B; Woodward M; Chalmers J, 2001, 'The lowering of blood pressure after stroke - Reply', LANCET, 358, pp. 1994 - 1995, http://dx.doi.org/10.1016/S0140-6736(01)06982-3

Cates C; Upton MN; D'Ambrosio M; Cruickshank J; MacMahon S; Rodgers A; Neal B; Woodward M; Chalmers J; Fournier A; Mazouz H; Choukroun G; Andrejak M; Godefroy O; Staessen JA; Wang JG; Thijs L, 2001, 'The lowering of blood pressure after stroke [1] (multiple letters)', Lancet, 358, pp. 1993 - 1996, http://dx.doi.org/10.1016/S0140-6736(01)06978-1

, 2001, 'Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (Vol 358, pg 1033, 2001)', LANCET, 358, pp. 1556 - 1556, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172055800065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Macmahon S; Tonkin A; Neal B; Hunt D; Richards M; Simes J; Wilcken D; Murphy J, 2001, 'Effects of omapatrilat on blood pressure and neurohormone levels among 723 individuals with coronary heart disease - The PACIFIC study', CIRCULATION, 104, pp. 601 - 601, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000171895002822&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

MacMahon S; Neal B; Tzourio C; Rodgers A; Woodward M; Cutler J; Anderson C; Chalmers J; Ohkubo T; Bouser MG; Davis S; Donnan G; Hansson L; Harrap S; Lees KR; Liu L; Mancia G; Omae T; Reid J; Sega R; Terent A; Warlow C; Anderson N; Bladin C; Chambers B; Gordon G; Sharpe N; Collins R; Sandercock P; Simes J; Sleight P; Brnabic A; Colman S; Francis L; Lee A; Gong L; Bousser MG; Yamaguchi T; William F; Deng Q; Hu DX; Wang W; Wu AL; Ma LY; Tao ZY; Biousse V; Berthet K; Ben Slamia L; Le Denmat C; Crespi S; Foglia G; Fujimoto C; Matsumura S; Marttala K; Pettersson M; Safwenberg M; Fenton J; McIlvenna Y; Currie R; Bartram H; Briad J; Clague A; Cleverly Y; Cosson M; Culpan A; Douglas D; Flett S; Gray B; Holloway T; Milne A; Prasad R; Ratnasabapathy Y; Santos A; Wills M; Agnew T; Chapman N; Lewis N; Mullane B, 2001, 'Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack', Lancet, 358, pp. 1033 - 1041, http://dx.doi.org/10.1016/S0140-6736(01)06178-5

Chalmers J; Cooper M; Ferrannini E; Glasziou P; Grobbee D; Hamet P; Harrap S; Liu L; MacMahon S; Mancia G; Marre M; Matthews D; Mogensen C; Neal B; Yu Pan C; Poulter N; Rodgers A; Williams B; Woodward M; Collins R; Sandercock P; Sleight P; Holman R; Fulcher G; Pollock C; Celermajer D; Watson J; Harrisberg B; Currie R; Girgis S; Jayne K; Monaghan H; Patel A; Richens A; Gray B; Milne A; Adderkin A; Bak A; Flett S; De Guise D; Jetses E; Reid J; Stolk R; Wang W; Williams F; Zou X, 2001, 'Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation', Diabetologia, 44, pp. 1118 - 1120, http://dx.doi.org/10.1007/s001250100612

Neal B, 2001, 'Commentary: Changing population blood pressure levels', British Medical Journal, 322, pp. 888 - 889

Neal B; MacMahon S; Tonkin A; Dudman N; Hunt D; Richards M; Simes J; Wilcken D; Brnabic A; Murphy J; Cleverley Y, 2001, 'Dose-dependent effects of folic acid on plasma homocysteine levels among 723 individuals with coronary heart disease: the PACIFIC study', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 37, pp. 280A - 280A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000166914401286&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chapman N; Neal B, 2001, 'Prospectively designed overviews of recent trials comparing antihypertensive regimens based on different drug classes', Current Hypertension Reports, 3, pp. 340 - 349, http://dx.doi.org/10.1007/s11906-001-0097-4

Chalmers J, 2001, 'Rationale and design of the advance study: A randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus', Journal of Hypertension, Supplement, 19

Neal B; MacMahon S; Chapman N; Cutler J; Fagard R; Whelton P; Yusuf S; Agodoa L; Baigent C; Black H; Boissel JP; Brenner B; Brown M; Bulpitt C; Byington R; Chalmers J; Collins R; Dahlof B; Davis B; Estacio R; Fox K; Hansson L; Holman R; Hunsicker L; Kostis J; Kuramoto K; Kusek J; Lees R; Lewis E; Lindholm LH; Liu L; Lubsen J; Malacco E; Mancia G; Martin I; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Remuzzi G; Rodgers A; Ruggenenti P; Schrier R; Sever P; Sleight P; Staessen J; Teo K; Turner R; Wing L; Zanchetti A; Algert C; Woodward M, 2000, 'Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials', Lancet, 356, pp. 1955 - 1964, http://dx.doi.org/10.1016/S0140-6736(00)03307-9

Chalmers J; Neal B; MacMahon S, 2000, 'PROGRESS (Perindopril Protection Against Recurrent Stroke Study): Regional characteristics of the study population at baseline', Journal of Hypertension, Supplement, 18

MacMahon S; Neal B, 2000, 'Differences between blood-pressure-lowering drugs', Lancet, 356, pp. 352 - 353, http://dx.doi.org/10.1016/S0140-6736(00)02521-6

O Brien J; Duncan H; Kirsh G; Allen V; King P; Hargraves R; Mendes L; Perera T; Catto P; Schofield S; Ploschke H; Hefner T; Churchland M; Woolnough S; Wuttke R; Manning M; Jeffries T; Hensley L; Bath P; Bainbridge D; Guinane F; McMahon L; Zavattaro D; Wilson D; Blake K; Morton J; Sharman D; Locke R; Ghabrial J; McNeil S; Rehfisch P; Van Der Merwe S; Einoder B; Douglas D; Ashwell J; Morrissey A; Brown A; Simm R; Fisch C; Crawford W; Everding T; Tanham D; Hooper J; Aldana C; Goldwasser M; Mibus M; Rowden N; Mills J; Johnson P; Stilwell J; Williams R; Stevenson T; Zwar J; Bauze R; Nyunt B; Russell R; Day G; Cameron M; Clements P; Beck T; Ellis A; Phipps S; Quaill W; Skirving A; McGuiness M; Gray P; Rankin J; Wood D; Senior J; Courtenay B; Green M; Harris I; Rush J; Kilgour M; Davies J; Newcombe J; Lewis C; Leitl S; Chilcott R; Pianta R; Aguila A; Hawe C; Nade S; Smith M; Robertson P; Rothwell A; May S; Williams S; Rothwell A; Shamy S; Martin G; Steele V; Jeffery K; Kelman I; McKillan J; Dayaram P; Culling J; Lawson D; Winfield P; Kuzel R, 2000, 'Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial', Lancet, 355, pp. 1295 - 1302, http://dx.doi.org/10.1016/S0140-6736(00)02110-3

Neal BC; Rodgers A; Clark T; Gray H; Reid IR; Dunn L; MacMahon SW, 2000, 'A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery', Acta Orthopaedica Scandinavica, 71, pp. 122 - 128, http://dx.doi.org/10.1080/000164700317413076

Neal BC; Rodgers A; Gray H; Clark T; Beaumont DD; House T; Douglas JE; Reid IR; MacMahon SW, 2000, 'No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients', Acta Orthopaedica Scandinavica, 71, pp. 129 - 134, http://dx.doi.org/10.1080/000164700317413085

Neal B; Rodgers A; Dunn L; Fransen M, 2000, 'Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.', Cochrane database of systematic reviews (Online)

Neal B, 2000, 'UNDER THE MICROSCOPE', Evidence-based Cardiovascular Medicine, 4, pp. 28 - 30, http://dx.doi.org/10.1054/ebcm.2000.0286

Zhang X; MacMahon S; Rodgers A; Neal B, 1999, 'Determinants of cardiovascular disease in the Asian Pacific Region: Protocol for a collaborative overview of cohort studies', CVD Prevention, 2, pp. 281 - 289

Rodgers A; Neal B, 1999, 'Less salt does not necessarily mean less taste', Lancet, 353, pp. 1332, http://dx.doi.org/10.1016/S0140-6736(99)01198-8

Chalmers J; MacMahon S; Mancia G; Whitworth J; Beilin L; Hansson L; Neal B; Rodgers A; Mhurchu CN; Clark T, 1999, '1999 World Health Organization International Society of Hypertension guidelines for the management of hypertension', JOURNAL OF HYPERTENSION, 17, pp. 151 - 183, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079235700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chalmers J, 1999, '1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension', Blood Pressure, Supplement, 8, pp. 9 - 43

Chalmers J; MacMahon S; Bousser MG; Cutler J; Donnan G; Hansson L; Harrap S; Liu L; Mancia G; Omae T; Reid J; Rodgers A; Warlow C, 1999, 'PROGRESS - Perindopril Protection Against Recurrent Stroke Study: Characteristics of the study population at baseline', Journal of Hypertension, 17, pp. 1647 - 1655

Neal B; MacMahon S, 1999, 'The world health organization- international society of hypertension blood pressure lowering treatment trialists' collaboration: Prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments', Current Hypertension Reports, 1, pp. 346 - 356, http://dx.doi.org/10.1007/s11906-999-0045-2

Neal B, 1999, 'Captopril and conventional treatment had similar effects on cardiovascular morbidity and mortality in patients with primary hypertension', Evidence-based Cardiovascular Medicine, 3, pp. 74 - 74, http://dx.doi.org/10.1054/ebcm.1999.0232

Black H; Boissel JP; Brenner B; Brown M; Bulpitt C; Chalmers J; Collins R; Cutler J; Dahlof B; Davis B; Fagard R; Fletcher A; Furberg C; Hansson L; Kuramoto K; Lewis E; MacMahon S; Mancia G; Pitt B; Poulter N; Remuzzi G; Sleight P; Turner R; Sever P; Whelton P; Wing L; Yusuf S; Zanchetti A; Martin I; Cohn J; Alderman M; Hansson L; Neal B; Rodgers A; Baigent C; Collins R, 1998, 'Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments', Journal of Hypertension, 16, pp. 127 - 137

NEAL B, 1998, 'Blood pressure and the risk of recurrent vascular disease', American Journal of Hypertension, 11, pp. 25A - 25A, http://dx.doi.org/10.1016/s0895-7061(97)90792-5

Alderman M; Arakawa K; Beilin L; Chalmers J; Cohn J; Collins R; Fenichel RR; Frohlich ED; Hamet P; Hansson L; Hennekens C; Kuschnir E; Lisheng L; MacMahon S; Mancia G; Martin I; Menard J; Sleight P; Whitworth J; Yusuf S; Zanchetti A; Neal B, 1997, 'Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding', Hypertension Research - Clinical and Experimental, 20, pp. 61 - 72

MacMahon S; Rodgers A; Neal B; Chalmers J, 1997, 'Blood pressure lowering for the secondary prevention of myocardial infarction and stroke', Hypertension, 29, pp. 537 - 538, http://dx.doi.org/10.1161/01.HYP.29.2.537

Chalmers J, 1997, 'Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding', Journal of Human Hypertension, 11, pp. 331 - 342, http://dx.doi.org/10.1038/sj.jhh.1000467

Neal B; Rodgers A; Mackie MJ; MacMahon S, 1996, 'Forty years of randomised trials in the New Zealand Medical Journal', New Zealand Medical Journal, 109, pp. 372 - 373

Neal B; Anderson C; Chalmers J; MacMahon S; Rodgers A, 1996, 'Blood pressure lowering in patients with cerebrovascular disease: Results of the progress (perindopril protection against recurrent stroke study) pilot phase', Clinical and Experimental Pharmacology and Physiology, 23, pp. 444 - 446, http://dx.doi.org/10.1111/j.1440-1681.1996.tb02758.x

Neal B; MacMahon S, 1995, 'PROGRESS (perindopril protection against recurrent stroke study): rationale and design. PROGRESS Management Committee [corrected]', Journal of hypertension, 13, pp. 1869 - 1873

Neal B; MacMahon S; Bousser MG; Chalmers J; Cutler J; Donnan G; Hansson L; Harrap S; Lisheng L; Mancia G; Menard J; Omae T; Reid J; Rodgers A, 1995, 'The PROGRESS study: Rationale and design', Journal of Hypertension, 13, pp. 1869 - 1873, http://dx.doi.org/10.1097/00004872-199512010-00068

Back to profile page